Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oruvail 200 modified-release capsules
1001010L0BDABAJ
|
Oruvail (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | 288 |
|
Oruvail 100 modified-release capsules
1001010L0BDAAAI
|
Oruvail (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | 135 |
|
Oruvail 150 modified-release capsules
1001010L0BDADAL
|
Oruvail (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Oruvail IM 100mg/2ml solution for injection ampoules
1001010L0BDACAG
|
Oruvail (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.